| |

Murthy Success
Story : Rapid
NIW
Approval
Posted
Jan 06, 2006
©MurthyDotCom
In November and
December of 2005,
MurthyDotCom
and MurthyBulletin readers were provided with examples of National
Interest Waiver (NIW) and Extraordinary Ability (EA) cases filed by the
Murthy Law Firm that received approvals. Our firm also received an NIW
approval remarkable for its speed. The case was filed just prior to
September 30, 2005, as part of our push to file eligible cases for nationals
of India before EB2 retrogression was to go into effect. Happily, it was
approved just one month later, at the end of October
2005. This is quite unusual and we are very pleased, as is our
client. The substance of the case follows. It is an example of the types of
proof and the arguments that have helped the Murthy Law Firm obtain
approvals in NIW cases for many of our clients.
©MurthyDotCom
Field of NIW Work
©MurthyDotCom
Our client conducted leading work in the field of Free Radical Chemistry.
The research focused on biosynthetic studies of potential anticancer
compounds. Cancer research generally can be shown to be in the national
interest, as the development of new cancer treatments is a high research
priority in the United States. Our client conducted important research on
free radicals, which are potentially harmful atoms or molecules within the
body. Free radicals react with body chemicals and can cause disease,
including cancer and immune-deficiency diseases. We argued that this
individual’s research is of substantial benefit to the health of U.S.
citizens and to the U.S. economy, as evidenced by research funding through
the National Institutes of Health (NIH) and the National Science Foundation
(NSF).
©MurthyDotCom
Documentary Evidence Submitted with NIW Filing
©MurthyDotCom
Our firm submitted reference letters on our client's behalf from U.S. and
international universities and private institutions. These expert opinion
letters stated, in sum, that our client is considered an international
leader in the field, who has made substantial contributions to the field of
cancer research. Nine publications were authored by this individual,
including articles in leading journals and invited book chapters. Our client
presented research at prestigious conferences, including the highly-select
Gordon Research Conferences. We were able to show that other researchers are
building upon our client's important and essential research findings, as
demonstrated by more than seventy favorable citations to the work that has
been done. This scientist is also a member of several professional
organizations related to the field, including Phi Lambda Upsilon and the
American Chemical Society.
©MurthyDotCom
Conclusion
©MurthyDotCom
We at the Murthy Law Firm would like to thank our client for agreeing to
share this information with MurthyDotCom and MurthyBulletin
readers. Our diligence in preparing this case prior to the EB2 retrogression
was rewarded with a remarkably prompt NIW approval. Visit our NIW section on MurthyDotCom
to read accounts of many other successes.
Copyright © 2006, MURTHY LAW
FIRM. All Rights Reserved

|
|